Pyxis Oncology announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors, effective March 12, 2024. Dr. Palani is a former investment partner and a current advisory partner at PFM Health Sciences, a leading healthcare investment advisory firm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PYXS:
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
- Pyxis Oncology Secures $50M Through Private Placement Deal
- Pyxis Oncology to sell 8.85M shares at $4.78 in private placement